Literature DB >> 11782106

The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both?

E F Torrey1, R H Yolken.   

Abstract

Schizophrenia and rheumatoid arthritis share an impressive number of similarities. Both are chronic, relapsing diseases of unknown etiology. Both became prominent in the early 19th century and have prevalences of approximately 1% in North America and Europe. Both run in families, have pairwise concordance rates of approximately 30% among monozygotic twins, and are more common among individuals born in urban areas. For both diseases, studies have reported greater exposure to cats in childhood than in controls. Both diseases have been associated with similar class II HLA antigens. Both have also been suspected of having infectious etiology, with similar agents--retroviruses, herpesviruses including EBV, and Toxoplasma gondii--having been associated in some cases. Since there is also a well-documented inverse correlation between these two diseases, it is possible that they share a common infectious and/or immune etiology and that once a person gets one of the diseases then they are relatively immune to the other. Copyright 2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11782106     DOI: 10.1006/brbi.2001.0649

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  34 in total

1.  Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia.

Authors:  Tsuyoshi Miyakawa; Lorene M Leiter; David J Gerber; Raul R Gainetdinov; Tatyana D Sotnikova; Hongkui Zeng; Marc G Caron; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-08       Impact factor: 11.205

Review 2.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

Review 3.  The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders.

Authors:  Emily G Severance; Dag Tveiten; Lief H Lindström; Robert H Yolken; Karl L Reichelt
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 4.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

5.  The association between schizophrenia and rheumatoid arthritis: a nationwide population-based Swedish study on intraindividual and familial risks.

Authors:  Carl Sellgren; Thomas Frisell; Paul Lichtenstein; Mikael Landèn; Johan Askling
Journal:  Schizophr Bull       Date:  2014-04-08       Impact factor: 9.306

6.  A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence.

Authors:  Dunja Hinze-Selch; Walter Däubener; Lena Eggert; Sükran Erdag; Renate Stoltenberg; Sibylle Wilms
Journal:  Schizophr Bull       Date:  2007-03-26       Impact factor: 9.306

7.  Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders.

Authors:  Oliver Frank; Michelle Giehl; Chun Zheng; Rüdiger Hehlmann; Christine Leib-Mösch; Wolfgang Seifarth
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Does Systemic Inflammation Play a Role in Pediatric Psychosis?

Authors:  Tatiana Falcone; Erin Carlton; Catherine Lee; Mattia Janigro; Vince Fazio; Fernando Espi Forcen; Kathleen Franco; Damir Janigro
Journal:  Clin Schizophr Relat Psychoses       Date:  2013-03-14

Review 9.  Schizophrenia and Infections: The Eyes Have It.

Authors:  E Fuller Torrey; Robert H Yolken
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

Review 10.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.